Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers Meeting Abstract


Authors: Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
Abstract Title: Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680302286
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.9100
Notes: Meeting Abstract: 9100 -- This meeting was also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Glenn Heller
    399 Heller
  2. Helena Alexandra Yu
    281 Yu
  3. Gregory J Riely
    599 Riely
  4. Mark Kris
    869 Kris
  5. Soo Ryum Yang
    75 Yang
  6. Christina Jade Falcon
    44 Falcon
  7. Antonio Marra
    44 Marra